glp 1 new How GLP-1 medications are transforming diabetes and weight loss treatment Most Patients Keep Weight Off

However, alternative glucose-lowering therapies are used adjunctively, but importantly are off-label in type 1 diabetes

Discover the key insights on the GLP-1 Drugs from the 2025 Pharmacy in Focus Report

These label expansions unlocked new pathways for coverage, and by early 2025 the proportion of Medicare patients with diabetes or obesity initiating GLP-1 therapy rose sharply

Purpose Manufacturing processes for polypeptide/protein drugs are designed to ensure robust quality, efficacy and safety

This review includes sections on anatomy and physiology, diagnosis and differential diagnosis as well as management and current guidelines for treatment of diabetic gastroparesis